Fibroblast growth factor receptor 2 promotes the proliferation, migration, and invasion of ectopic stromal cells via activation of extracellular-signal-regulated kinase signaling pathway in endometriosis

References

• Facchin F, Barbara G, Saita E, et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol. 2015;36(4):135–141.
   PubMed Web of Science ®Google Scholar
• Luscombe GM, Markham R, Judio M, et al. Abdominal bloating: an under-recognized endometriosis symptom. J Obstetrics Gynaecol Can JOGC. 2009;31(12):1159–1171.
   PubMedGoogle Scholar
• Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017;96(6):659–667.
   PubMed Web of Science ®Google Scholar
• Carpinello OJ, Sundheimer LW, Alford CE, et al. Endometriosis. In: Feingold KR, Anawalt B, Boyce A, et al, eds. Endotext. South Dartmouth (MA): MDText.com, Inc 2017 .Copyright © 20002021, MDText.com, Inc., 2000.Copyright © 20002021, MDText.com, Inc., 2000.
   Google Scholar
• Mehedintu C, Plotogea MN, Ionescu S, et al. Endometriosis still a challenge. J Med Life. 2014;7(3):349–357.
   PubMedGoogle Scholar
• García-Gómez E, Vázquez-Martínez ER, Reyes-Mayoral C, et al. Regulation of inflammation pathways and inflammasome by sex steroid hormones in endometriosis. Front Endocrinol (Lausanne). 2019;10:935.
   PubMed Web of Science ®Google Scholar
• He Y, Xiong T, Guo F, et al. Interleukin-37b inhibits the growth of murine endometriosis-like lesions by regulating proliferation, invasion, angiogenesis and inflammation. Mol Hum Reprod. 2020;26(4):240–255.
   PubMed Web of Science ®Google Scholar
• Ganieva U, Nakamura T, Osuka S, et al. Involvement of transcription factor 21 in the pathogenesis of fibrosis in endometriosis. Am J Pathol. 2020;190(1):145–157.
   PubMed Web of Science ®Google Scholar
• Touat M, Ileana E, Postel-Vinay S, et al. Targeting FGFR signaling in cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2015;21(12):2684–2694.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wong CC, Leung KT. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential. Oncogene. 2020;39(43):6647–6663.
   PubMed Web of Science ®Google Scholar
• Krook MA, Lenyo A, Wilberding M. Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma. Molecular Cancer Therapeutics. 2020;19(3):847–857.
   PubMed Web of Science ®Google Scholar
• Mathur A, Ware C, Davis L, et al. FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival. PloS one. 2014;9(6):e98515.
   PubMed Web of Science ®Google Scholar
• Byron SA, Pollock PM. FGFR2 as a molecular target in endometrial cancer. future oncology (London. England). 2009;5:27–32.
   Google Scholar
• Gatius S, Velasco A, Azueta A, et al. FGFR2 alterations in endometrial carcinoma. Mod Pathol. 2011;24(11):1500–1510.
   PubMed Web of Science ®Google Scholar
• Gredler ML, Seifert AW, Cohn MJ. Tissue-specific roles of Fgfr2 in development of the external genitalia. Development (Cambridge. England). 2015;142:2203–2212.
   Google Scholar
• Katoh M. FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies. J Invest Dermatol. 2009;129:1861–1867.
   PubMed Web of Science ®Google Scholar
• Li C, Guo H, Xu X, et al. Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning. Dev Dyn. 2001;222(3):471–483.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science (New York, NY). 2002;298(5600):1911–1912.
   Google Scholar
• DuShane JK, Wilczek MP, Mayberry CL, et al. ERK is a critical regulator of JC polyomavirus infection. J Virol. 2018;92(7). DOI:10.1128/JVI.01529-17
   PubMed Web of Science ®Google Scholar
• Liu P, Pan Q. Butein inhibits oxidative stress injury in rats with chronic heart failure via ERK/Nrf2 Signaling. Cardiovascular Therapeutics. 2022;2022:8684014.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang Y, Dettinger P. Cytokine combinations for human blood stem cell expansion induce cell-type- and cytokine-specific signaling dynamics. Blood. 2021;138(10):847–857.
   PubMed Web of Science ®Google Scholar
• Ning M, Qin S, Tian J, et al. LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway. Bioengineered. 2021;12(1):1543–1554.
   PubMed Web of Science ®Google Scholar
• Najafi M, Ahmadi A, Mortezaee K. Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review. Cell Biology International. 2019;43(11):1206–1222.
   PubMed Web of Science ®Google Scholar
• Yang CY, Wang J, Zhang JQ, et al. Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway. Bioengineered. 2021;12(1):4432–4441.
   PubMed Web of Science ®Google Scholar
• Rai SN, Dilnashin H, Birla H, et al. The role of PI3K/Akt and ERK in neurodegenerative disorders. Neurotox Res. 2019;35(3):775–795.
   PubMed Web of Science ®Google Scholar
• Gallo S, Vitacolonna A, Bonzano A, et al. ERK: a key player in the pathophysiology of cardiac hypertrophy. Int J Mol Sci. 2019;20:2164. doi:10.3390/ijms20092164 .
   PubMed Web of Science ®Google Scholar
• Huang H, Ni H, Ma K, et al. ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy. Am J Transl Res. 2019;11(9):5472–5486.
   PubMed Web of Science ®Google Scholar
• Santulli P, Marcellin L, Tosti C, et al. MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? Expert Opin Ther Targets. 2015;19(11):1465–1483.
   PubMed Web of Science ®Google Scholar
• Makker A, Goel MM, Das V, et al. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol. 2012;28(3):175–181.
   PubMed Web of Science ®Google Scholar
• Lee WL, Chang WH, Wang KC, et al. The risk of epithelial ovarian cancer of women with endometriosis may be varied greatly if diagnostic criteria are different: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94(39):e1633.
   PubMed Web of Science ®Google Scholar
• Guo X, Xu X, Li T, et al. NLRP3 inflammasome activation of mast cells by estrogen via the nuclear-initiated signaling pathway contributes to the development of endometriosis. Front Immunol. 2021;12:749979.
   PubMed Web of Science ®Google Scholar
• Saito A, Osuga Y, Yoshino O, et al. TGF-β1 induces proteinase-activated receptor 2 (PAR2) expression in endometriotic stromal cells and stimulates PAR2 activation-induced secretion of IL-6. human reproduction. Vol. 26, ; 2011. 1892–1898. doi:10.1093/humrep/der125.
   Google Scholar
• Young VJ, Ahmad SF, Duncan WC, et al. The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum Reprod Update. 2017;23(5):548–559.
   PubMed Web of Science ®Google Scholar
• Ranieri D, Rosato B, Nanni M, et al. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition. Oncotarget. 2016;7(5):5440–5460.
   PubMedGoogle Scholar
• Baraniak AP, Lasda EL, Wagner EJ, et al. A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements. Mol Cell Biol. 2003;23(24):9327–9337.
   PubMed Web of Science ®Google Scholar
• Guo M, Liu W, Serra S, et al. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression. Cancer Res. 2012;72(8):2017–2027.
   PubMed Web of Science ®Google Scholar
• Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376:1835–1848.
   PubMed Web of Science ®Google Scholar
• Shafrir AL, Farland LV, Shah DK, et al. Risk for and consequences of endometriosis: a critical epidemiologic review. Best Pract Res Clin Obstetrics Gynaecol. 2018;51:1–15.
   PubMed Web of Science ®Google Scholar
• Huang T, Liu D, Wang Y, et al. FGFR2 promotes gastric cancer progression by inhibiting the expression of thrombospondin4 via PI3K-Akt-Mtor pathway. Cell Physiol Biochem. 2018;50(4):1332–1345.
   PubMedGoogle Scholar
• Li P, Huang T, Zou Q. FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway. Journal of Immunology (Baltimore, Md.: 1950). 2019;202(10):3065–3075.
   PubMed Web of Science ®Google Scholar
• McKinnon BD, Kocbek V, Nirgianakis K, et al. Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics. Hum Reprod Update. 2016;22(3):382–403.
   PubMed Web of Science ®Google Scholar
• Leconte M, Santulli P, Chouzenoux S, et al. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis. Reproductive sciences (Thousand OaksCalif). 2015;22:1171–1180.
   PubMed Web of Science ®Google Scholar
• Park S, Lim W, You S, et al. Ameliorative effects of luteolin against endometriosis progression in vitro and in vivo. J Nutr Biochem. 2019;67:161–172.
   PubMed Web of Science ®Google Scholar
• Terakawa J, Rocchi A, Serna VA, et al. FGFR2IIIb-MAPK activity is required for epithelial cell fate decision in the lower müllerian duct. Mol Endocrinol (Baltimore, Md). 2016;30(7):783–795.
   PubMedGoogle Scholar